Literature DB >> 24764687

Squamous cell carcinoma after radiofrequency ablation for Barrett's dysplasia.

Sebastian S Zeki1, Rehan Haidry1, Manuel Justo-Rodriguez1, Laurence B Lovat1, Nicholas A Wright1, Stuart A McDonald1.   

Abstract

Barrett's oesophagus (BO) is a usually indolent condition that occasionally requires endoscopic therapy. Radiofrequency ablation (RFA) is an effective endoscopic treatment for high grade dysplasia (HGD) and intramucosal cancer in BO. It has a good efficacy, durability and safety profile although complications can occur. Here we describe a case of RFA in a patient with high grade dysplasia. Although the response to treatment was initially very good with the development of neosquamous epithelium, the patient very rapidly developed a squamous cell cancer of the oesophagus confirmed on radiology, histology and immunohistochemistry. Sanger sequencing confirmed that the original HGD and the squamous cell cancer (SCC) were derived from separate clonal origins. The report highlights the fact that SCC of the oesophagus has been noted after endoscopic ablation for BO previously and suggest that ablation of BO may encourage the clonal expansion of cells carrying carcinogenic mutations once a dominant clonal population has been eradicated.

Entities:  

Keywords:  Barrett’s oesophagus; High grade dysplasia; Radiofrequency ablation; Squamous carcinoma oesophagus; Squamous cell cancer

Mesh:

Year:  2014        PMID: 24764687      PMCID: PMC3989985          DOI: 10.3748/wjg.v20.i15.4453

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  12 in total

1.  Durability of radiofrequency ablation in Barrett's esophagus with dysplasia.

Authors:  Nicholas J Shaheen; Bergein F Overholt; Richard E Sampliner; Herbert C Wolfsen; Kenneth K Wang; David E Fleischer; Virender K Sharma; Glenn M Eisen; M Brian Fennerty; John G Hunter; Mary P Bronner; John R Goldblum; Ana E Bennett; Hiroshi Mashimo; Richard I Rothstein; Stuart R Gordon; Steven A Edmundowicz; Ryan D Madanick; Anne F Peery; V Raman Muthusamy; Kenneth J Chang; Michael B Kimmey; Stuart J Spechler; Ali A Siddiqui; Rhonda F Souza; Anthony Infantolino; John A Dumot; Gary W Falk; Joseph A Galanko; Blair A Jobe; Robert H Hawes; Brenda J Hoffman; Prateek Sharma; Amitabh Chak; Charles J Lightdale
Journal:  Gastroenterology       Date:  2011-05-06       Impact factor: 22.682

Review 2.  Risk factors for squamous cell carcinoma of the oesophagus.

Authors:  U Ribeiro; M C Posner; A V Safatle-Ribeiro; J C Reynolds
Journal:  Br J Surg       Date:  1996-09       Impact factor: 6.939

3.  Barrett's metaplasia glands are clonal, contain multiple stem cells and share a common squamous progenitor.

Authors:  Anna M Nicholson; Trevor A Graham; Ashley Simpson; Adam Humphries; Nicola Burch; Manuel Rodriguez-Justo; Marco Novelli; Rebecca Harrison; Nicholas A Wright; Stuart A C McDonald; Janusz A Jankowski
Journal:  Gut       Date:  2011-12-26       Impact factor: 23.059

4.  Squamous cell carcinoma in Barrett's esophagus: field effect versus metastasis.

Authors:  M M Streppel; P D Siersema; W W de Leng; F H Morsink; F P Vleggaar; A Maitra; E A Montgomery; G J Offerhaus
Journal:  Dis Esophagus       Date:  2012-01-03       Impact factor: 3.429

5.  Patterns of recurrent and persistent intestinal metaplasia after successful radiofrequency ablation of Barrett's esophagus.

Authors:  Robert J Korst; Sobeida Santana-Joseph; John R Rutledge; Arthur Antler; Vivian Bethala; Anthony DeLillo; Donald Kutner; Benjamin E Lee; Haleh Pazwash; Robert H Pittman; Michael Rahmin; Mitchell Rubinoff
Journal:  J Thorac Cardiovasc Surg       Date:  2012-12-06       Impact factor: 5.209

6.  Esophageal squamous cell carcinoma arising after endoscopic ablation therapy of Barrett's esophagus with high-grade dysplasia. Report of a case.

Authors:  D Allende; J Dumot; L Yerian
Journal:  Dis Esophagus       Date:  2012-09-25       Impact factor: 3.429

7.  Radiofrequency ablation in Barrett's esophagus with dysplasia.

Authors:  Nicholas J Shaheen; Prateek Sharma; Bergein F Overholt; Herbert C Wolfsen; Richard E Sampliner; Kenneth K Wang; Joseph A Galanko; Mary P Bronner; John R Goldblum; Ana E Bennett; Blair A Jobe; Glenn M Eisen; M Brian Fennerty; John G Hunter; David E Fleischer; Virender K Sharma; Robert H Hawes; Brenda J Hoffman; Richard I Rothstein; Stuart R Gordon; Hiroshi Mashimo; Kenneth J Chang; V Raman Muthusamy; Steven A Edmundowicz; Stuart J Spechler; Ali A Siddiqui; Rhonda F Souza; Anthony Infantolino; Gary W Falk; Michael B Kimmey; Ryan D Madanick; Amitabh Chak; Charles J Lightdale
Journal:  N Engl J Med       Date:  2009-05-28       Impact factor: 91.245

8.  Development of subsquamous high-grade dysplasia and adenocarcinoma after successful radiofrequency ablation of Barrett's esophagus.

Authors:  Mohammad Titi; Andrew Overhiser; Ozlem Ulusarac; Gary W Falk; Amitabh Chak; Kenneth Wang; Prateek Sharma
Journal:  Gastroenterology       Date:  2012-05-03       Impact factor: 22.682

Review 9.  High-temperature beverages and foods and esophageal cancer risk--a systematic review.

Authors:  Farhad Islami; Paolo Boffetta; Jian-Song Ren; Leah Pedoeim; Dara Khatib; Farin Kamangar
Journal:  Int J Cancer       Date:  2009-08-01       Impact factor: 7.396

10.  Individual crypt genetic heterogeneity and the origin of metaplastic glandular epithelium in human Barrett's oesophagus.

Authors:  S J Leedham; S L Preston; S A C McDonald; G Elia; P Bhandari; D Poller; R Harrison; M R Novelli; J A Jankowski; N A Wright
Journal:  Gut       Date:  2008-02-27       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.